Literature DB >> 9285663

Right ventricular dilation in primary amyloidosis: an independent predictor of survival.

A R Patel1, S W Dubrey, L A Mendes, M Skinner, A Cupples, R H Falk, R Davidoff.   

Abstract

This study was designed to characterize the geometry and function of the right ventricle and its prognostic significance in patients with primary (AL) cardiac amyloidosis. AL amyloidosis is an infiltrative systemic disease that can result in thickening of heart structures and rapidly progressive congestive heart failure due to restrictive ventricular physiology and eventual systolic dysfunction. Thirty-seven patients with AL amyloid heart involvement and 20 normal control subjects were evaluated using 2-dimensional and Doppler echocardiography. Based on the ratio of left-to-right end-diastolic ventricular chamber areas, patients were classified into 2 groups: 25 patients with disproportionate right ventricular (RV) dilation (left ventricular to RV ratio < or = 2) and 12 with a ventricular area ratio > 2. Patients with a relatively dilated right ventricle (ratio < or = 2) had a shorter median survival (4 months) compared with patients with an area ratio > 2 (10 months, p <0.003). Of multiple clinical, echocardiographic, and Doppler features entered into a multifactorial model, a ventricular area ratio < or = 2 remained the only independent predictor of survival. Patients with AL amyloid heart disease represent a heterogeneous population with regard to both prognosis and the relative degree of right to left ventricular dilation. RV dilation in patients with amyloid heart disease appears to be associated with more severe involvement and is associated with a very poor prognosis with a median survival of only 4 months.

Entities:  

Mesh:

Year:  1997        PMID: 9285663     DOI: 10.1016/s0002-9149(97)00400-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

Review 1.  Echocardiographic evaluation of cardiac amyloid.

Authors:  Wendy Tsang; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

2.  Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Koichiro Kuwahara; Tsutomu Katsuyama; Kazutoshi Maruyama
Journal:  J Echocardiogr       Date:  2019-02-11

Review 3.  How to Image Cardiac Amyloidosis: A Practical Approach.

Authors:  Sharmila Dorbala; Sarah Cuddy; Rodney H Falk
Journal:  JACC Cardiovasc Imaging       Date:  2019-10-11

4.  Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).

Authors:  Taslima Bhuiyan; Stephen Helmke; Ayan R Patel; Frederick L Ruberg; Jeff Packman; Kin Cheung; Donna Grogan; Mathew S Maurer
Journal:  Circ Heart Fail       Date:  2010-12-29       Impact factor: 8.790

Review 5.  Echocardiography in cardiac amyloidosis.

Authors:  Rodney H Falk; C Cristina Quarta
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

Review 6.  Echocardiographic assessment of cardiac amyloidosis.

Authors:  Tanushree Agrawal; Sherif F Nagueh
Journal:  Heart Fail Rev       Date:  2021-08-30       Impact factor: 4.654

Review 7.  Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.

Authors:  Walid Hassan; Hani Al-Sergani; Walid Mourad; Rashed Tabbaa
Journal:  Tex Heart Inst J       Date:  2005

Review 8.  Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.

Authors:  James A White; Nowell M Fine
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

9.  Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis.

Authors:  Frederick L Ruberg; Evan Appelbaum; Ravin Davidoff; Al Ozonoff; Kraig V Kissinger; Caitlin Harrigan; Martha Skinner; Warren J Manning
Journal:  Am J Cardiol       Date:  2008-12-25       Impact factor: 2.778

10.  Updates in cardiac amyloidosis: a review.

Authors:  Sanjay M Banypersad; James C Moon; Carol Whelan; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.